Strength
4.6 mg/24h
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
70710119607
Classification
Generic
Dosage Form
PATCH, EXTENDED RELEASE
Route
TRANSDERMAL
Last Updated
4/22/2026
Active Ingredients
RIVASTIGMINEApproval Type
Generic (ANDA)
FDA Application
ANDA206318On Market Since
3/6/2019
Pharmacological Classes
Cholinesterase Inhibitor
Cholinesterase Inhibitors
Related Drugs
Same classification
DONEPEZIL HCL 5 MG TABLET
Generic
00904647761•Major Pharmaceuticals
$0.0440
per EA
DONEPEZIL HCL 5 MG TABLET
Generic
13668010210•Torrent Pharmaceuticals Limited
$0.0440
per EA
DONEPEZIL HCL 5 MG TABLET
Generic
13668010230•Torrent Pharmaceuticals Limited
$0.0440
per EA
DONEPEZIL HCL 5 MG TABLET
Generic
13668010290•Torrent Pharmaceuticals Limited
$0.0440
per EA
DONEPEZIL HCL 5 MG TABLET
Generic
16571077803•Rising Pharma Holdings Inc.
$0.0440
per EA
DONEPEZIL HCL 5 MG TABLET
Generic
16571077809•Rising Pharma Holdings Inc.
$0.0440
per EA
DONEPEZIL HCL 5 MG TABLET
Generic
16571077810•Rising Pharma Holdings Inc.
$0.0440
per EA
DONEPEZIL HCL 5 MG TABLET
Generic
16571077850•Rising Pharma Holdings Inc.
$0.0440
per EA
DONEPEZIL HCL 5 MG TABLET
Generic
31722073705•Camber Pharmaceuticals Inc.
$0.0440
per EA
DONEPEZIL HCL 5 MG TABLET
Generic
31722073730•Camber Pharmaceuticals Inc.
$0.0440
per EA